Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 23 April 1999: Vol. 284. no. 5414, pp. 647 - 650 DOI: 10.1126/science.284.5414.647
|
|
Reports
Nonproteolytic Neuroprotection by Human Recombinant Tissue Plasminogen Activator
Yang-Hee Kim,
12
June-Hee Park,
1
Seung Hwan Hong,
2
Jae-Young Koh
1*
Human recombinant tissue plasminogen activator (tPA) may benefit
ischemic stroke patients by dissolving clots. However, independent of
thrombolysis, tPA may also have deleterious effects on neurons by
promoting excitotoxicity. Zinc neurotoxicity has been shown to be an
additional key mechanism in brain injuries. Hence, if tPA affects zinc
neurotoxicity, this may provide additional insights into its effect on
neuronal death. Independent of its proteolytic action, tPA markedly
attenuated zinc-induced cell death in cortical culture, and, when
injected into cerebrospinal fluid, also reduced kainate
seizure-induced hippocampal neuronal death in adult rats.
1 National Creative Research Initiative Center
for the Study of Central Nervous System Zinc and Department of
Neurology, University of Ulsan College of Medicine, 388-1 Poongnap-Dong
Songpa-Gu, Seoul 138-736, Korea.
2 Department of
Molecular Biology and Institute for Molecular Biology and Genetics,
Seoul National University, Seoul, Korea.
*
To whom correspondence should be addressed. E-mail:
jkko{at}www.amc.seoul.kr
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Inhibition of integrin {alpha}V{beta}3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia.
- J. W. Kiessling, D. B. Cines, A. A.-R. Higazi, and W. M. Armstead (2009)
Am J Physiol Heart Circ Physiol
296, H862-H867
| Abstract »
| Full Text »
| PDF »
- Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
- M. Kremen, R. Krishnan, I. Emery, J. H. Hu, K. I. Slezicki, A. Wu, K. Qian, L. Du, A. Plawman, A. Stempien-Otero, et al. (2008)
PNAS
105, 17109-17114
| Abstract »
| Full Text »
| PDF »
- Role of thrombolytic agents in cardiac arrest..
- D K Pedley and W G Morrison (2006)
Emerg. Med. J.
23, 747-752
| Abstract »
| Full Text »
| PDF »
- Nitric Oxide and Zinc Homeostasis in Acute Lung Injury.
- C. M. St. Croix, K. Leelavaninchkul, S. C. Watkins, V. E. Kagan, and B. R. Pitt (2005)
Proceedings of the ATS
2, 236-242
| Abstract »
| Full Text »
| PDF »
- Plasminogen Activators Contribute to Impairment of Hypercapnic and Hypotensive Cerebrovasodilation After Cerebral Hypoxia/Ischemia in the Newborn Pig.
- W. M. Armstead, D. B. Cines, and A. A.-R. Higazi (2005)
Stroke
36, 2265-2269
| Abstract »
| Full Text »
| PDF »
- N,N,N',N'-Tetrakis(2-pyridylmethyl)-ethylenediamine Improves Myocardial Protection against Ischemia by Modulation of Intracellular Ca2+ Homeostasis.
- Y. A. Shmist, R. Kamburg, G. Ophir, A. Kozak, V. Shneyvays, Y. J. Appelbaum, and A. Shainberg (2005)
J. Pharmacol. Exp. Ther.
313, 1046-1057
| Abstract »
| Full Text »
| PDF »
- Vampire Bat Salivary Plasminogen Activator (Desmoteplase) Inhibits Tissue-Type Plasminogen Activator-Induced Potentiation of Excitotoxic Injury.
- C. Reddrop, R. X. Moldrich, P. M. Beart, M. Farso, G. T. Liberatore, D. W. Howells, K.-U. Petersen, W.-D. Schleuning, and R. L. Medcalf (2005)
Stroke
36, 1241-1246
| Abstract »
| Full Text »
| PDF »
- Vampire Bat Salivary Plasminogen Activator (Desmoteplase): A Unique Fibrinolytic Enzyme That Does Not Promote Neurodegeneration.
- G. T. Liberatore, A. Samson, C. Bladin, W.-D. Schleuning, and R. L. Medcalf (2003)
Stroke
34, 537-543
| Abstract »
| Full Text »
| PDF »
- Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
- S. Brodsky, J. Chen, A. Lee, K. Akassoglou, J. Norman, and M. S. Goligorsky (2001)
Am J Physiol Heart Circ Physiol
281, H1784-H1792
| Abstract »
| Full Text »
| PDF »
- Loss of Hippocampal Serine Protease BSP1/Neuropsin Predisposes to Global Seizure Activity.
- B. Davies, I. R. Kearns, J. Ure, C. H. Davies, and R. Lathe (2001)
J. Neurosci.
21, 6993-7000
| Abstract »
| Full Text »
| PDF »
- Role of zinc in pulmonary endothelial cell response to oxidative stress.
- Z.-L. Tang, K. Wasserloos, C. M. St. Croix, and B. R. Pitt (2001)
Am J Physiol Lung Cell Mol Physiol
281, L243-L249
| Abstract »
| Full Text »
| PDF »
- Potentiation of NMDA Receptor Function by the Serine Protease Thrombin.
- M. B. Gingrich, C. E. Junge, P. Lyuboslavsky, and S. F. Traynelis (2000)
J. Neurosci.
20, 4582-4595
| Abstract »
| Full Text »
| PDF »
- The Plasmin System Is Induced by and Degrades Amyloid-beta Aggregates.
- H. M. Tucker, M. Kihiko, J. N. Caldwell, S. Wright, T. Kawarabayashi, D. Price, D. Walker, S. Scheff, J. P. McGillis, R. E. Rydel, et al. (2000)
J. Neurosci.
20, 3937-3946
| Abstract »
| Full Text »
| PDF »
- Tissue Plasminogen Activator-Mediated Fibrinolysis Protects against Axonal Degeneration and Demyelination after Sciatic Nerve Injury.
- K. Akassoglou, K. W. Kombrinck, J. L. Degen, and S. Strickland (2000)
J. Cell Biol.
149, 1157-1166
| Abstract »
| Full Text »
| PDF »
- Zinc-Induced Cortical Neuronal Death: Contribution of Energy Failure Attributable to Loss of NAD+ and Inhibition of Glycolysis.
- C. T. Sheline, M. M. Behrens, and D. W. Choi (2000)
J. Neurosci.
20, 3139-3146
| Abstract »
| Full Text »
| PDF »
- Role of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation.
- M. Zhuo, D. M. Holtzman, Y. Li, H. Osaka, J. DeMaro, M. Jacquin, and G. Bu (2000)
J. Neurosci.
20, 542-549
| Abstract »
| Full Text »
| PDF »
- Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system.
- A. Rogove, C Siao, B Keyt, S Strickland, and S. Tsirka (1999)
J. Cell Sci.
112, 4007-4016
| Abstract »
| PDF »
|
|